4-(N-(Butylcarbamoyl)sulfamoyl)benzoic acid
Names
[ CAS No. ]:
2224-10-4
[ Name ]:
4-(N-(Butylcarbamoyl)sulfamoyl)benzoic acid
[Synonym ]:
Carboxytolbutamide
N-Butyl-N'-(4-carboxyphenylsulfonyl)urea
4-(butylcarbamoylsulfamoyl)benzoic acid
Chemical & Physical Properties
[ Density]:
1.337g/cm3
[ Melting Point ]:
210-212ºC
[ Molecular Formula ]:
C12H16N2O5S
[ Molecular Weight ]:
300.33100
[ Exact Mass ]:
300.07800
[ PSA ]:
120.95000
[ LogP ]:
3.03540
[ Index of Refraction ]:
1.558
MSDS
Safety Information
[ Symbol ]:
GHS05
[ Signal Word ]:
Danger
[ Hazard Statements ]:
H318
[ Precautionary Statements ]:
P280-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
41
[ Safety Phrases ]:
26-39
[ RIDADR ]:
NONH for all modes of transport
[ HS Code ]:
2935009090
Synthetic Route
Customs
[ HS Code ]: 2935009090
[ Summary ]:
2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0%
Articles
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 871(1) , 78-89, (2008)
A reliable liquid chromatography/tandem mass spectrometry has been developed for simultaneous evaluation of the activities of five cytochrome P450s (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A) in rat ...
Eur. J. Clin. Pharmacol. 60(3) , 165-71, (2004)
The hypoglycaemic drug tolbutamide is used for assessment of CYP2C9 activity in vivo. However, therapeutically active doses of 500 mg bear the risk of hypoglycaemia, and a tolbutamide-derived paramete...
Ther. Drug Monit. 21(6) , 664-71, (1999)
An isocratic, high-performance liquid chromatography method has been developed for simultaneous determination of the oral antidiabetic tolbutamide and two of its metabolites, 4-hydroxytolbutamide and ...